(Q72706155)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6192218%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6192218%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

25 August 2023

author name string

G. Vervliet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192218

25 August 2023

H. Claeys

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192218

25 August 2023

H. Van Haver

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192218

25 August 2023

H. Carton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192218

25 August 2023

C. Vermylen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192218

25 August 2023

E. Meulepas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192218

25 August 2023

A. Billiau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192218

25 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6192218

25 August 2023

publication date

1 July 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6192218%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

https://api.elsevier.com/content/article/PII:0022510X83901338?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

https://api.elsevier.com/content/article/PII:0022510X83901338?httpAccept=text/plain

25 August 2023

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Journal of the Neurological Sciences

25 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6192218%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6192218%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6192218%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

137-150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6192218%20AND%20SRC:MED&resulttype=core&format=json

Antibodies to Oligodendroglia in Patients with Multiple Sclerosis

28 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Identification of a unique idiotype in cerebrospinal fluid and serum of a patient with multiple sclerosis

25 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

The significance of the association between HLA and multiple sclerosis

25 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Interferons and the immune system

25 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Large-scale Production of Human Leukocyte Interferon Containing 108 Units per ml

25 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Activation of natural cytotoxicity of human peripheral blood mononuclear cells by interferon: a kinetic study and comparison of different interferon types

25 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Interferon induced in human leukocytes by mitogens: production, partial purification and characterization

25 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

The preparation of antibodies directed against human immune interferon

25 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Augmentation of mouse natural killer cell activity by interferon and interferon inducers

25 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Defective mitogenic responses in myasthenia gravis and multiple sclerosis

25 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Interferon Induction by Heat-Inactivated Semliki Forest Virus

25 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Natural killer cell activity in multiple sclerosis

25 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

25 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis

25 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Neurologic impairment in multiple sclerosis and the disability status scale.

25 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Leukocyte iso- and autoantibodies in multiple sclerosis (MS) with special regard to complement-dependent cold-reacting auto-lymphocytotoxins (CoCoCy)

25 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains

25 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis

25 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Interferon responses of leukocytes in multiple sclerosis

25 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States

25 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Defective production of interferon-alpha associated with HLA-DW2 antigen in stable multiple sclerosis

25 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

PPD-, PWM-, and PHA-induced interferon in stable multiple sclerosis: association with HLA-Dw2 antigen and clinical variables

25 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis

25 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Lymphocytotoxic antibodies in multiple sclerosis

25 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Interferon Production by Semliki Forest Virus Inactivated with Hydroxylamine

25 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Multiple sclerosis and cell-mediated hypersensitivity to myelin A1 protein

25 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

25 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Natural Killer Cell Activity in Patients with Multiple Sclerosis: Interferon and Plasmapheresis

25 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants

25 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Induction of Interferon in Human Lymphoblastoid Cells by Sendai and Measles Viruses

25 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

Natural killing activity and interferon production in multiple sclerosis

25 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0022-510X(83)90133-8

25 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6192218%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference